Grant: Catalyst Grant: Avian Influenza OneHealth Research
Université Laval
$150,000.00
Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?
EF 2024-25
Résumé
H5N1 'bird-flu' viruses have been a global public health concern since they were first identified in humans in 1997. Over the last 25 years, they have infected wild birds and several mammals. In 2024, an H5N1 virus infection was found for the first time in dairy cattle in the USA and it has spread to about 140 herds in 12 US states with infection of farm cats, poultry and humans, highlighting a public health risk. The goal of our research is to be prepared to treat cases of human H5N1 infection. We will use the two commercially available anti-influenza drugs that attack different parts of the virus to test how well the drugs work by themselves and together, to treat H5N1 infection. We have laboratory models that reflect healthy people and people who have weak immune systems. Our research will help doctors treat patients with H5N1 infections and will help public health officials plan in case the H5N1 virus spreads from cattle in the US to Canada.
Programme
Catalyst Grant: Avian Influenza OneHealth Research
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
507197
Name
Baz Etchebarne Mariana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Catalyzing OneHealth Research on Avian Influenza
Projecttitle
Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Avian Influenza OneHealth Research
Keyworddelim
Aerosol Transmission; Antiviral Resistance; Bioinformatics; Fda Approved Antivirales; Hamsters; Highly Pathogenic Avian Influenza; Histopathology; Nose And Small And Large-Airway; Pathogenesis; Zoonotic Viruses
Abstract
H5N1 'bird-flu' viruses have been a global public health concern since they were first identified in humans in 1997. Over the last 25 years, they have infected wild birds and several mammals. In 2024, an H5N1 virus infection was found for the first time in dairy cattle in the USA and it has spread to about 140 herds in 12 US states with infection of farm cats, poultry and humans, highlighting a public health risk. The goal of our research is to be prepared to treat cases of human H5N1 infection. We will use the two commercially available anti-influenza drugs that attack different parts of the virus to test how well the drugs work by themselves and together, to treat H5N1 infection. We have laboratory models that reflect healthy people and people who have weak immune systems. Our research will help doctors treat patients with H5N1 infections and will help public health officials plan in case the H5N1 virus spreads from cattle in the US to Canada.
Competitiondate
202407
Approvedterm2
1 yr 0 mth
Pinamesdelim
Baz Etchebarne, Mariana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $150,000~ $0~